Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs

NARecruitingINTERVENTIONAL
Enrollment

3,200

Participants

Timeline

Start Date

December 9, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Cervical CancerScreening
Interventions
DIAGNOSTIC_TEST

Screening with HPV test

Women aged 25-49 yrs will be screened with a validated HPV test. They will also provide urine samples for HPV test. Women HPV positive in either sample will be referred to colposcopy for disease ascertainment.

Trial Locations (1)

0002

RECRUITING

Bothwell Guzha, Harare

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

collaborator

University of Zimbabwe

OTHER

collaborator

Lancaster University

OTHER

collaborator

Neo Sense Vector (NSV)

UNKNOWN

collaborator

National Cancer Institute (NCI)

NIH

lead

International Agency for Research on Cancer

OTHER